Yuyu Pharma Cash Flow Quality Index
Yuyu Pharma cash flow quality index. Yuyu Pharma (000220) has a Cash Flow Quality Index of 0.21x as of September 2025. Operating cash flow of ₩836.62 Million is below net income of ₩3.98 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore debt repayment capacity of Yuyu Pharma to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Yuyu Pharma (2011–2024)
Cash flow quality index of Yuyu Pharma from 2011 to 2024. Historical Cash Flow Quality Index for Yuyu Pharma across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. See Yuyu Pharma (000220) net asset quality to measure how much of total assets are equity-financed.
Yuyu Pharma Cash Flow Quality Index by Year (2011–2024)
Yuyu Pharma cash flow quality index by year from 2011 to 2024. Year-by-year earnings quality comparison for Yuyu Pharma. For the full cash flow conversion analysis, see cash efficiency ratio of Yuyu Pharma.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 2.86x | ₩24.95 Billion | ₩8.72 Billion | ▲ +237.6% |
| 2020 | -2.08x | ₩-2.67 Billion | ₩1.28 Billion | ▼ -174.5% |
| 2019 | 2.79x | ₩13.19 Billion | ₩4.72 Billion | ▲ +83.7% |
| 2018 | 1.52x | ₩6.11 Billion | ₩4.02 Billion | ▲ +1584.3% |
| 2017 | 0.09x | ₩561.35 Million | ₩6.22 Billion | ▼ -94.6% |
| 2016 | 1.67x | ₩9.82 Billion | ₩5.89 Billion | ▲ +450.8% |
| 2013 | -0.48x | ₩-775.17 Million | ₩1.63 Billion | ▼ -120.1% |
| 2012 | 2.36x | ₩6.51 Billion | ₩2.76 Billion | ▼ -47.8% |
| 2011 | 4.52x | ₩6.67 Billion | ₩1.48 Billion | — |